These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15229952

  • 1. Cyclophosphamide boluses induce micronuclei expression in buccal mucosa cells of patients with systemic lupus erythematosus independent of cytochrome P450 2D6 status.
    Aceves Avila FJ, Esquivel Nava GA, Gallegos Arreola MP, Gómez Meda B, Zúñiga González G, Ramos-Remus C.
    J Rheumatol; 2004 Jul; 31(7):1335-9. PubMed ID: 15229952
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy.
    Mok CC, Lau CS, Wong RW.
    Arthritis Rheum; 1998 May; 41(5):831-7. PubMed ID: 9588734
    [Abstract] [Full Text] [Related]

  • 3. Ovarian failure and flares of systemic lupus erythematosus.
    Mok CC, Wong RW, Lau CS.
    Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
    [Abstract] [Full Text] [Related]

  • 4. Micronucleus frequency in peripheral blood lymphocytes from patients with systemic lupus erythematosus.
    Severin E.
    Rom J Morphol Embryol; 1995 Jun; 41(1-2):55-8. PubMed ID: 8680026
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM.
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [Abstract] [Full Text] [Related]

  • 6. Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus.
    Somers EC, Marder W, Christman GM, Ognenovski V, McCune WJ.
    Arthritis Rheum; 2005 Sep; 52(9):2761-7. PubMed ID: 16142702
    [Abstract] [Full Text] [Related]

  • 7. Cytochrome P450 polymorphism as a predictor of ovarian toxicity to pulse cyclophosphamide in systemic lupus erythematosus.
    Singh G, Saxena N, Aggarwal A, Misra R.
    J Rheumatol; 2007 Apr; 34(4):731-3. PubMed ID: 17407229
    [Abstract] [Full Text] [Related]

  • 8. Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus.
    Bertsias GK, Nakou M, Choulaki C, Raptopoulou A, Papadimitraki E, Goulielmos G, Kritikos H, Sidiropoulos P, Tzardi M, Kardassis D, Mamalaki C, Boumpas DT.
    Arthritis Rheum; 2009 Jan; 60(1):207-18. PubMed ID: 19116915
    [Abstract] [Full Text] [Related]

  • 9. Association of a CD24 gene polymorphism with susceptibility to systemic lupus erythematosus.
    Sánchez E, Abelson AK, Sabio JM, González-Gay MA, Ortego-Centeno N, Jiménez-Alonso J, de Ramón E, Sánchez-Román J, López-Nevot MA, Gunnarsson I, Svenungsson E, Sturfelt G, Truedsson L, Jönsen A, González-Escribano MF, Witte T, German Systemic Lupus Erythematosus Study Group, Alarcón-Riquelme ME, Martín J.
    Arthritis Rheum; 2007 Sep; 56(9):3080-6. PubMed ID: 17763438
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Cyclophosphamide induced amenorrhoea in pre-menopausal women with systemic lupus erythematosus].
    Cunha I, Saavedra MJ, Pereira da Silva JA, Malcata A.
    Acta Reumatol Port; 2008 Sep; 33(1):69-76. PubMed ID: 18344924
    [Abstract] [Full Text] [Related]

  • 12. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 13. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
    Gambelunghe G, Gerli R, Bocci EB, Del Sindaco P, Ghaderi M, Sanjeevi CB, Bistoni O, Bini V, Falorni A.
    Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
    [Abstract] [Full Text] [Related]

  • 14. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G, Sánchez E, González-Gay MA, López-Nevot MA, Torres B, Cáliz R, Ortego-Centeno N, Jiménez-Alonso J, Pascual-Salcedo D, Balsa A, de Pablo R, Nuñez-Roldan A, González-Escribano MF, Martín J.
    Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
    Her M, Kim D, Oh M, Jeong H, Choi I.
    Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC, Ying KY, Ng WL, Lee KW, To CH, Lau CS, Wong RW, Au TC.
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [Abstract] [Full Text] [Related]

  • 18. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M, Yazisiz V, Sallakci N, Avci AB, Sanlioglu S, Yegin O, Terzioglu E.
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [Abstract] [Full Text] [Related]

  • 19. Association of mannose binding lectin (MBL) gene polymorphism and serum MBL concentration with characteristics and progression of systemic lupus erythematosus.
    Takahashi R, Tsutsumi A, Ohtani K, Muraki Y, Goto D, Matsumoto I, Wakamiya N, Sumida T.
    Ann Rheum Dis; 2005 Feb; 64(2):311-4. PubMed ID: 15647440
    [Abstract] [Full Text] [Related]

  • 20. CYP2D6 polymorphism in systemic lupus erythematosus patients.
    Kortunay S, Bozkurt A, Bathum L, Basci NE, Calgüneri M, Brøsen K, Kayaalp SO.
    Eur J Clin Pharmacol; 1999 Mar; 55(1):21-5. PubMed ID: 10206080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.